Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
March 13, 2024 16:26 ET
|
Enzo Biochem, Inc.
FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024. ...
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
February 01, 2024 08:30 ET
|
Enzo Biochem, Inc.
FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meeting...
ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
December 15, 2023 16:20 ET
|
Enzo Biochem, Inc.
FARMINGDALE, NY, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the first quarter ended October 31, 2023. ...
ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
November 06, 2023 08:00 ET
|
Enzo Biochem, Inc.
FARMINGDALE, NY, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fourth quarter ended July 31, 2023, and the...
Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
October 30, 2023 16:15 ET
|
Enzo Biochem, Inc.
FARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading life sciences company, announced today that Steven J. Pully has been appointed...
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
September 06, 2023 08:30 ET
|
Enzo Biochem, Inc.
FARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of...
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
July 24, 2023 16:27 ET
|
Enzo Biochem, Inc.
Significant value unlocked for Enzo shareholders with continued focus on life sciences. FARMINGDALE, NY, July 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) today announced that it...
Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results
June 14, 2023 19:21 ET
|
Enzo Biochem, Inc.
- Enzo Life Sciences reports revenue of $7.5 million, with margin improvement in Q3 FY23 FARMINGDALE, NY, June 14, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a pioneering...
Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale
May 22, 2023 09:20 ET
|
Enzo Biochem, Inc.
FARMINGDALE, NY, May 22, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), announced today that the preliminary voting results from the Inspector of Election at today’s Special Meeting of...
Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders
April 24, 2023 16:05 ET
|
Enzo Biochem, Inc.
FARMINGDALE, NY, April 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo Biochem” or the “Company”), a leading biosciences and diagnostics company, today announced that its special...